Currently, taking glucose sensitizing agents, including metformin, SGLT-2 inhibitor, and GLP-1 agonist, is an effective way of lowering insulin levels and controlling PDA development at the same time
Licensed 503A compounding pharmacies can fill prescriptions from clinicians in most states today
14 Little is known about the capacity of exogenously administered GSH, or its precursors, to modify CNS GSH levels
Many people report brain fog alongside low mood or anxiety
Neurotrophins such as BDNF and NGF play central roles in synaptic plasticity, neuronal survival, and network organization, and their dysregulation may represent a more proximal mechanism underlying behavioral impairments